Kaia Health has raised $75 million in a Series C funding round to further develop its AI-assisted digital therapies, available via a mobile app focused on chronic pain related to musculoskeletal disorders (MSK) and chronic obstructive pulmonary disease (COPD). The New York-based healthtech frontrunner attracted interest from an unnamed private equity fund that led the […]